SCHEMBL12419409

SCHEMBL12419409

OB(O)c1ccc(Oc2ccc3c(c2)CCO3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
PRKCI P41743 1/20 0.43
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
ERN1 O75460 3/20 0.40
ALOX5 P09917 4/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
DYRK1A Q13627 1/20 0.37
ENPP2 Q13822 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8895 0.82 PRKCI (0.51) PRKCIERN1HDAC3HDAC4HDAC1
SCHEMBL2937683 0.78 PRKCI (0.47) CA1CA2PRKCICA12CA9
SCHEMBL31180358 0.78 PRKCI (0.47) CA1CA2PRKCICA12CA9
SCHEMBL10269417 0.76 ALDH1A1 (0.63) CA1CA2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL10734397 0.76 NPBWR1 (0.41) CA1CA2PRKCICA12CA9
SCHEMBL7931568 0.74 PRKCI (0.46) CA1CA2PRKCICA12CA9
SCHEMBL1656413 0.74 KDM4C (0.49) CA1CA2PRKCICA12CA9
SCHEMBL29952451 0.72 CTNNB1 (0.46) PRKCIERN1HDAC3HDAC4HDAC1
SCHEMBL470297 0.72 CTNNB1 (0.46) PRKCIERN1HDAC3HDAC4HDAC1
SCHEMBL6001606 0.72 CA2 (0.81) CA1CA2ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 CA1 822/4885CA2 1487/4885PRKCI 2190/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 CA1 822/4885CA2 1487/4885PRKCI 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.